GAITHERSBURG, Md., March 30, 2020 — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medication firm harnessing the facility of molecular diagnostics and informatics to assist fight infectious illness, introduced in the present day that, following its Particular Assembly of Shareholders held March 30, 2020, OpGen shareholders overwhelmingly voted to approve the proposed enterprise mixture with Curetis N.V. Our molecular diagnostics and informatics merchandise, product candidates and providers mix our Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform to be used with our proprietary, curated MDRO knowledgebase. OpGen, Inc. is a precision drugs firm harnessing the ability of molecular diagnostics and informatics to assist fight infectious illness. Pizzaforcoins is an organization that accepts crypto funds and in reality, settle for round 50 kinds of crypto coins making it tremendous-handy for shoppers. read more